Cite
APA Citation
Chabria, S., De Wit, S., Pierce, A., Shepherd, B. M., Warwick-Sanders, M., Du, F., Wang, M., Clark, A., & Ackerman, P. (n.d.). 834. Characterization of Heavily Treatment Experienced HIV-1 Infected Clinical Trial Participants Infected with SARS-CoV-2 COVID 19: Fostemsavir BRIGHTE Phase 3 Clinical Trial. Open forum infectious diseases, 8, S509. http://access.bl.uk/ark:/81055/vdc_100150543095.0x00001a